Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trialChristopher Koh, Theo Heller, Mark A. Winters et al.|The Lancet Infectious Diseases|2015Cited by 262
Characteristics of Congenital Hepatic Fibrosis in a Large Cohort of Patients With Autosomal Recessive Polycystic Kidney DiseaseMeral Gunay‐Aygun, Theo Heller, Esperanza Font–Montgomery et al.|Gastroenterology|2012Cited by 179
Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical TrialJeffrey B. Kopp, Frederick J. Kaskel, Cheryl A. Winkler et al.|Journal of the American Society of Nephrology|2015Cited by 126